Incidence of ineffective safety margin testing (<10 J) and efficacy of routine subcutaneous array insertion during implantable cardioverter defibrillator implantation.
The purpose of this study was to assess (1) the incidence of safety margin testing <10 J (SMT) and (2) the efficacy/safety of routinely adding a subcutaneous array (SQA) (Medtronic 6996SQ) for these patients. Patients with SMT smaller than a 10-J safety margin from maximum output were considered to have very high readings and underwent SQA insertion. These patients were compared with the rest of the patients who had acceptable SMT (≥10 J). A total of 616 patients underwent ICD implantation during the analysis period. Of those, 16 (2.6%) had SMT <10 J. By univariate analysis, younger age, and non-ischemic cardiomyopathy, were all significant predictors of SMT <10 J (p < 0.05). In all 16 cases, other methods to improve SMT prior to array insertion were attempted but failed for all patients: reversing shock polarity (n = 15), removing the superior vena cava coil (n = 14), reprogramming shock waveform (n = 9), and repositioning right ventricular lead (n = 9). Addition of the SQA successfully increased SMT to within safety margin for all patients (32 ± 2 versus 21 ± 3 J; p < 0.001). Follow-up (mean 48.1 ± 21 months) was available for all patients with SQA, only 2 cases with inappropriate shocks due to atrial fibrillation had to be noted. None of the patients experienced complications due to SQA implantation. SMT <10 J occur in about 2.6% of patients undergoing ICD implantation. SQA insertion corrects this problem without procedural/mid-term complications.
Department of Cardiology, Zentralklinik, Robert-Koch-Allee 9, 99437 Bad Berka, Germany. Electronic address: marc.ohlow@zentralklinik.de.
Marc-Alexander
MA
Ohlow
Clinic for Electrophysiology, Heart Center, Salzburger Leite 1, 67616 Bad Neustadt, Germany.
Marcus
M
Roos
Department of Cardiology, Zentralklinik, Robert-Koch-Allee 9, 99437 Bad Berka, Germany.
Bernward
B
Lauer
Department of Invasive Electrophysiology, Zentralklinik, Robert-Koch-Allee 9, 99437 Bad Berka, Germany.
J Christoph
JC
Geller
Implantable cardioverter-defibrillator; Risk factors; Safety margin testing; Subcutaneous array
Circulation. 1992 Oct;86(4):1206-16
1394927
Heart Rhythm. 2005 May;2(5):456-61
15840466
Lancet. 2015 Feb 28;385(9970):785-91
25715991
Eur J Cardiothorac Surg. 2009 Mar;35(3):489-92
19144533
Anesth Analg. 2002 Nov;95(5):1147-53, table of contents
12401582
Pacing Clin Electrophysiol. 2000 May;23(5):842-6
10833704
Am J Cardiol. 1997 Jun 15;79(12 ):1623-7
9202352
Am J Cardiol. 1997 Jan 15;79(2):150-3
9193014
J Am Coll Cardiol. 2012 Sep 11;60(11):988-9
22858385
J Am Coll Cardiol. 2008 Aug 12;52(7):551-6
18687249
J Cardiovasc Electrophysiol. 2007 Jul;18(7):722-5
17472714
Pacing Clin Electrophysiol. 1998 Dec;21(12):2596-605
9894650
J Cardiovasc Electrophysiol. 2010 Dec;21(12):1344-8
20662988
J Cardiovasc Electrophysiol. 2001 Aug;12(8):921-7
11513444
Heart Rhythm. 2013 Apr;10(4):e11-58
23473952
Pacing Clin Electrophysiol. 1995 Aug;18(8):1540-8
7479175
J Am Coll Cardiol. 2012 Sep 11;60(11):981-7
22858384
Cardiol J. 2007;14(5):463-9
18651506